News Summary

Kyle Braatz, CEO of Ottawa-based Fullscript, shared insights into the company’s growth to a $2.5 billion USD valuation, emphasizing a startup approach in building each business segment. Founded in 2012, Fullscript has achieved $1 billion USD in revenue over the past 12 months by focusing on the wellness sector, providing a platform for over 100,000 providers to prescribe treatment plans to more than 10 million patients. The company adopted a slow and steady growth strategy, bolstered by acquisitions such as Rupa Health and Natural Partners. Fullscript’s unique approach includes treating each new venture as a startup, focusing on market leadership and innovation, particularly in lab testing and clinical decision support. Despite avoiding the IPO market for now, Braatz sees it as a potential future step. His deep ties to the Ottawa community and commitment to building a supportive entrepreneurial environment have been critical to Fullscript’s success.